To explore the signaling pathway of tumor FOXP3, we found that FOXP3 could significantly downregulate oncogene c-Myc in HCC cells and our Reactome pathway analysis indicated that FOXP3 might act on the TGFβ/Smads pathway to exert its inhibitory function. The gene discussed is MYC; the disease is hepatocellular carcinoma.